Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 6/20 | 0.37 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245173 | 0.92 | OTUD7B (0.36) | OTUD7BIP6K1NPY5RALOX5CRBN | |
| SCHEMBL30890440 | 0.80 | NR1H2 (0.35) | OTUD7BIP6K1 | |
| SCHEMBL27245125 | 0.80 | MAPT (0.38) | OTUD7BALOX5POLBLMNAALDH1A1 | |
| SCHEMBL30992253 | 0.79 | IMPDH2 (0.39) | OTUD7BIP6K1 | |
| SCHEMBL27244814 | 0.74 | L3MBTL1 (0.33) | LMNAALDH1A1 | |
| SCHEMBL27245205 | 0.73 | TDP1 (0.34) | — | |
| SCHEMBL27244904 | 0.73 | OTUD7B (0.37) | OTUD7B | |
| Hydrochloric Acid SCHEMBL27245049 | 0.73 | OTUD7B (0.33) | OTUD7BIP6K1NPY5RALOX5CRBN | |
| SCHEMBL30890630 | 0.72 | OTUD7B (0.37) | OTUD7BIP6K1NPY5RALOX5CRBN | |
| SCHEMBL27244749 | 0.70 | OTUD7B (0.38) | OTUD7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | EIF2AK2, ZC3HAV1, HAVCR2 | OTUD7B 2426/4885IP6K1 2977/4885NPY5R 4625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.